T1	Participants 220 313	patients treated for localized prostatic carcinoma in a Phase III radiotherapy (RT) protocol,
T2	Participants 361 579	Patients with T18N0M0 (A2) or T2N0M0 (B) disease after lymphangiogram (LAG) or staging laparotomy (SL) were randomized between prophylactic radiation to the pelvic lymph nodes and prostatic bed vs. prostatic bed alone.
T3	Participants 718 807	A total of 449 eligible males were entered into RTOG protocol 7706 between 1978 and 1983.
T4	Participants 886 926	patients had SL, while 332 (74%) had LAG
